VTVT UP 47% ,Nice pull back for entry before Lunch Buyers push higher. Yahoo Target $6.50 Current $3.12 up 47%
" vTv Therapeutics Announces Positive Results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399, Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes GlobeNewswire GlobeNewswire•February 10, 2020 "
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.